Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Steven Lee Chang
Results of a Phase II Trial of Neoadjuvant Abiraterone + Prednisone+ Enzalutamide + Leuprolide (APEL) Versus Enzalutamide + Leuprolide (EL) for Patients With High-Risk Localized Prostate Cancer (PC) Undergoing Radical Prostatectomy (RP).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Feasibility of Neoadjuvant Ad-Reic Gene Therapy in Patients With High-Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
Clinical and Translational Science
Genetics
Molecular Biology
Pharmacology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Neoadjuvant Enzalutamide Prior to Prostatectomy
Clinical Cancer Research
Cancer Research
Oncology
Pd14-05 Neoadjuvant Enzalutamide and Androgen Deprivation in High-Risk Prostate Cancer: Initial Imaging and Surgical Findings From a Phase Ii Clinical Trial
Journal of Urology
Urology
A Multicenter Phase I/Ii Study of Enzalutamide in Japanese Patients With Castration-Resistant Prostate Cancer
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Eyeing Enzalutamide for Hormone-Sensitive Prostate Cancer
Cancer Discovery
Oncology
Does Diabetes Mellitus Increase the Risk of High-Grade Prostate Cancer in Patients Undergoing Radical Prostatectomy?
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients With Oligo-Progression During Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Pharmacoeconomic Evaluation of Enzalutamide, Abiraterone and Cabazitaxel for the Treatment of Post-Chemotherapy Patients With Metastatic Castration-Resistant Prostate Cancer
Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
Klinicka Onkologie
Oncology
